Enlasia Pharmaceuticals Private Limited
About Enlasia Pharmaceuticals Private Limited
Data last updated: 13 July 2025
Enlasia Pharmaceuticals Private Limited was a private limited company based in Gurugram, Haryana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It specialised in specialised services, a part of the broader trading and commerce sector. Incorporated on 30 July 2018.
Registered with ROC Delhi under CIN U51909HR2018PTC075143.
Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Rakesh Mittal and Chhaya Bhatnagar.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Office No. 581/17 Nai Basti Gurugram, Haryana, India – 122001.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.71 Lakh, a growth of 139% compared to the previous year.
The company is no longer operational and has been struck off from the Register of Companies, typically due to non-filing of annual returns or failure to commence business. Entering into any agreement with a struck-off entity carries significant legal and financial risk.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social MediaLocked
-
Registered AddressOffice No. 581/17 Nai Basti Gurugram, Haryana, India – 122001
-
IndustryTrading, Specialty, Wholesale
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Board of Directors of Enlasia Pharmaceuticals Private Limited
Enlasia Pharmaceuticals Private Limited is governed by 2 directors who oversee the company's operations and strategic decisions.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Mittal | Director | 30 Jul 2018 | 8 Years 0 Months | As last reported |
| Chhaya Bhatnagar | Director | 30 Jul 2018 | 8 Years 0 Months | As last reported |
Financials of Enlasia Pharmaceuticals Private Limited FY 2024 filings available
Enlasia Pharmaceuticals Private Limited reported revenue of ₹1.71 Lakh (up 139.00% YoY) for FY 2023.
Ten-year financial statements for Enlasia Pharmaceuticals Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Enlasia Pharmaceuticals Private Limited
Shareholding and ownership data for Enlasia Pharmaceuticals Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings Enlasia Pharmaceuticals Private Limited
Enlasia Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Enlasia Pharmaceuticals Private Limited
View historical data on people associated with Enlasia Pharmaceuticals Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Enlasia Pharmaceuticals Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Enlasia Pharmaceuticals Private Limited
GST registrations and filing compliance for Enlasia Pharmaceuticals Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Enlasia Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts for Enlasia Pharmaceuticals Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Enlasia Pharmaceuticals Private Limited
MSME payment history for Enlasia Pharmaceuticals Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Enlasia Pharmaceuticals Private Limited
Corporate group structure for Enlasia Pharmaceuticals Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Enlasia Pharmaceuticals Private Limited
MCA filings and documents for Enlasia Pharmaceuticals Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Enlasia Pharmaceuticals Private Limited
Frequently Asked Questions about Enlasia Pharmaceuticals Private Limited
Enlasia Pharmaceuticals Private Limited has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Enlasia Pharmaceuticals Private Limited is a struck-off private limited company in the trading sector based in Gurugram, Haryana, India. It was incorporated on 30 July 2018 and is registered under CIN U51909HR2018PTC075143. The company has been struck off by the Registrar of Companies and is no longer operational.
The current directors of Enlasia Pharmaceuticals Private Limited are:
- Rakesh Mittal - Director
- Chhaya Bhatnagar - Director
The CIN (Corporate Identification Number) of Enlasia Pharmaceuticals Private Limited is U51909HR2018PTC075143. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The primary industry of Enlasia Pharmaceuticals Private Limited is trading. The company specifically operates in specialty. The company was active in this sector before being struck off.
The company has its registered office at Office No. 58117 Nai Basti Gurugram, Haryana, India – 122001.